Community Forum: Spotlight on CF Research

Register now to attend Cystic Fibrosis Canada’s 2025 Community Forum: Spotlight on CF Research. Hear from a stellar line-up of Canadian cystic fibrosis researchers sharing about their latest research projects, made possible with funding from Cystic Fibrosis Canada thanks to you, our donors, volunteers and supporters. Research topics include: CF related diabetes, infections and a new horizon in CF research: genetic therapies.

Date: June 18, 2025
Time: 2:00 – 3:30 p.m. ET
Location: Online via Zoom
Languages: English & French, with live simultaneous interpretation
Registration: Open now!

Co-hosted by Dr. Paul Eckford, Cystic Fibrosis Canada’s Chief Scientific Officer and Phoebe Dey, Chief Marketing Officer, this 90-minute session will include:

• Explore cystic fibrosis related diabetes research
• Insights into the future of genetic therapies for CF
• Opportunities to ask questions and engage directly with CF Canada staff, and researchers.

Speakers include:

• Dr. Adèle Coriati, PhD, Assistant Professor - Focusing on cystic fibrosis related diabetes research
  - Dr. Adèle Coriati is an assistant professor in the Department of Nutrition at the Université de Montréal and a researcher at the Jean-Jacques-Gauthier Center and Hôpital du Sacré-Cœur in Montreal. She co-led the development of the first Canadian guidelines on cystic fibrosis-related diabetes (CFRD). As co-director of the Montreal Cystic Fibrosis cohort, her research focuses on how new treatments, like CFTR modulators, are changing the way complications such as CFRD and obesity develop over time. One of her goals is to identify early warning signs, such as specific changes in blood lipids, that could help predict who might be at risk of developing diabetes.
• Dr. Dao Nguyen, MD, MSc, FRCPC - Sharing research on chronic bacterial infections in people with cystic fibrosis, 2025 Cathleen Morrison Research Award Recipient.
  - Dao Nguyen is Associate Professor of Medicine at McGill University, an adult respirologist at the McGill University Health Centre and a scientist at the Research Institute of the McGill University Health Centre. She is a Chercheur de Mérite of the Fonds de Recherche Santé Québec, and past recipient of career awards from the Canadian Institutes of Health, Burroughs Wellcome Fund and Cystic Fibrosis Canada. Her research is focused on the microbiology and host-pathogen interactions in Pseudomonas aeruginosa and cystic fibrosis lung disease, as well as the mechanisms of antibiotic tolerance and novel antimicrobial discovery. She is also interested in new diagnostic and therapeutic innovations that can help address the rising threat of antimicrobial resistance. To help advance research and build an interdisciplinary scientific community to fight against antimicrobial resistance, she is the founding director of the McGill AntiMicrobial Resistance Centre.
  
• Dr. Larry Lands, MD, PhD - Deep diving into gene therapy advancements
  ­- Dr. Larry Lands, MD, PhD, is Director, Pediatric Respiratory Medicine and Director of the Pediatric Cystic Fibrosis (CF) Clinic at the McGill University Health Centre, and an attending staff physician in the Quebec Lung Transplant Clinic, Centre Hospitalier d’Université de Montréal, and consultant to the CF clinic at Hôpital de Rouyn-Noranda. He is a tenured Full Professor of Pediatrics at McGill University. He is Chair of CF Canada’s Research Advisory Council, and Co-Chair of the protocol review committee of CF Canada’s clinical research network, CFCanACT. He is past-Chair of the Canadian Thoracic Society Research Committee. He is a member of the board of the Canadian Lung Association, and chairs its Research Committee. Beginning in 2025, Dr. Lands and colleagues were funded by Génome Québec and CF Canada to develop Prime Editing therapies for people living with CF with mutations that do not respond to highly effective modulators.

This forum is a chance to hear directly from experts and deepen your understanding of the latest in CF research and emerging treatments.

Can’t attend live? A recording will be shared after the event to those who register.